Cargando…
Detection and preliminary evaluation of circulating tumor cells in the peripheral blood of patients with eight types of cancer using a telomerase-specific adenovirus
We developed a detection method for circulating tumor cells (CTCs) using the telomerase-specific adenovirus OBP-401. This recombinant virus has a telomerase promoter at the 5′-end of the viral genome and GFP at the 3′-end. To date, CTC enumeration using OBP-401 has shown prognostic impact for gastri...
Autores principales: | YABUSAKI, MINA, SATO, JUN, KOHYAMA, ATSUSHI, KOJIMA, TAKASHI, NOBUOKA, DAISUKE, YOSHIKAWA, TOSHIAKI, SAWADA, YU, MURAKAMI, KATSUHIRO, GOHDA, KEIGO, OKEGAWA, TAKATSUGU, NAKAMURA, MASARU, TAKAMATSU, KIYOSHI, ITO, MASAAKI, KANEKO, KAZUHIRO, NAKATSURA, TETSUYA |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4203327/ https://www.ncbi.nlm.nih.gov/pubmed/25176113 http://dx.doi.org/10.3892/or.2014.3436 |
Ejemplares similares
-
Peptide vaccines for hepatocellular carcinoma
por: Nobuoka, Daisuke, et al.
Publicado: (2013) -
Peptide intra-tumor injection for cancer immunotherapy: Enhancement of tumor cell antigenicity is a novel and attractive strategy
por: Nobuoka, Daisuke, et al.
Publicado: (2013) -
Identification of an H2-K(b) or H2-D(b) restricted and glypican-3-derived cytotoxic T-lymphocyte epitope peptide
por: IWAMA, TATSUAKI, et al.
Publicado: (2013) -
Analysis of cytotoxic T lymphocytes from a patient with hepatocellular carcinoma who showed a clinical response to vaccination with a glypican-3-derived peptide
por: TADA, YOSHITAKA, et al.
Publicado: ( 201) -
Remarkable tumor lysis in a hepatocellular carcinoma patient immediately following glypican-3-derived peptide vaccination: An autopsy case
por: Sawada, Yu, et al.
Publicado: (2013)